Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Läckeby Djursjukhus
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Läckeby Djursjukhus

June 11, 2012

Vinge has advised Djursjukhusgruppen i Sverige in connection with the acquisition of Läckeby Djursjukhus. Djursjukhusgruppen is one of the leading participants within Swedish veterinary care and provides care for more than 100 000 pets per year.

Vinge’s team consisted of, among others, Jonas Bergström, Gustav Jönsson and Robin Dangoor.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026